The writer is director-general of the International Federation of Pharmaceutical Manufacturers
We all want a coronavirus vaccine. But no matter how urgently action is needed, it is imperative that the highest standards of quality, safety and efficacy are upheld.
Russia’s decision to approve mass use of its “Sputnik 5” vaccine after just two months of human trials is deeply troubling. Efforts by other countries to push through their own candidates at breakneck speed are also problematic.
您已阅读13%（490字），剩余87%（3389字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。